ATA977475A - Verfahren zur herstellung von neuen 2-amino-3-(5- bzw. 6-)-benzoylphenylessigsaeuren, ihren alkylestern und salzen - Google Patents
Verfahren zur herstellung von neuen 2-amino-3-(5- bzw. 6-)-benzoylphenylessigsaeuren, ihren alkylestern und salzenInfo
- Publication number
- ATA977475A ATA977475A AT977475A AT977475A ATA977475A AT A977475 A ATA977475 A AT A977475A AT 977475 A AT977475 A AT 977475A AT 977475 A AT977475 A AT 977475A AT A977475 A ATA977475 A AT A977475A
- Authority
- AT
- Austria
- Prior art keywords
- alkylesters
- benzoylphenyl
- amino
- salt
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/604,371 US4045576A (en) | 1975-08-13 | 1975-08-13 | Anti-inflammatory methods using 2-amino-3-(5- and 6-)benzoylphenylacetic acids, esters and metal salts thereof and the compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA977475A true ATA977475A (de) | 1978-05-15 |
AT347433B AT347433B (de) | 1978-12-27 |
Family
ID=24419335
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT429873A AT329542B (de) | 1975-08-13 | 1973-05-16 | Verfahren zur herstellung von neuen 2-amino-3 bzw. 5-benzoylphenylessigsauren |
AT977475A AT347433B (de) | 1975-08-13 | 1975-12-22 | Verfahren zur herstellung von neuen 2-amino-3- (5- bzw. 6-)-benzoylphenylessigsaeuren, ihren alkylestern und salzen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT429873A AT329542B (de) | 1975-08-13 | 1973-05-16 | Verfahren zur herstellung von neuen 2-amino-3 bzw. 5-benzoylphenylessigsauren |
Country Status (15)
Country | Link |
---|---|
US (3) | US4045576A (de) |
JP (3) | JPS523381B2 (de) |
AT (2) | AT329542B (de) |
AU (1) | AU530940B2 (de) |
BE (2) | BE799611A (de) |
CA (2) | CA1012979A (de) |
CH (1) | CH577461A5 (de) |
DE (2) | DE2324768C2 (de) |
ES (1) | ES446625A1 (de) |
FR (1) | FR2184934B1 (de) |
GB (2) | GB1432576A (de) |
MX (1) | MX4035E (de) |
NL (1) | NL183722C (de) |
PH (2) | PH12656A (de) |
SE (1) | SE400966B (de) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE400966B (sv) * | 1975-08-13 | 1978-04-17 | Robins Co Inc A H | Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror |
FR2366015A1 (fr) * | 1975-11-05 | 1978-04-28 | Robins Co Inc A H | Nouveaux acides amino-2 benzoyl-3 (5 et 6) phenylacetiques et leurs esters et sels de metaux alcalins, utiles notamment comme anti-inflammatoires, et leur procede de preparation |
US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
EP0089426B1 (de) * | 1979-07-12 | 1986-06-11 | A.H. Robins Company, Incorporated | 2-Amino-6-biphenylessigsäuren |
IL60444A (en) * | 1979-08-01 | 1985-03-31 | Robins Co Inc A H | 2-amino-3-(alkylthiobenzoyl)-phenylacetic acid derivatives and pharmaceutical compositions containing them |
ZA805476B (en) * | 1979-09-26 | 1981-11-25 | Robins Co Inc A H | 2-amino-3-benzoyl-phenylacetamides and cyclic homologues |
US4313949A (en) * | 1979-09-26 | 1982-02-02 | A. H. Robins Company, Inc. | Method of producing an inhibitory effect on blood platelet aggregation |
US4254146A (en) * | 1979-10-18 | 1981-03-03 | A. H. Robins Company, Inc. | 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters |
IL61945A (en) * | 1980-02-19 | 1984-09-30 | Robins Co Inc A H | 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them |
US4503073A (en) * | 1981-01-07 | 1985-03-05 | A. H. Robins Company, Incorporated | 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids |
IL64724A0 (en) * | 1981-02-17 | 1982-03-31 | Robins Co Inc A H | 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them |
JPS6019753A (ja) * | 1983-07-13 | 1985-01-31 | Shionogi & Co Ltd | オルト−(モノ置換アミノ)フエニルイミン類およびその製造法 |
JPS6026586U (ja) * | 1983-07-29 | 1985-02-22 | 日本軽金属株式会社 | 改装サッシ窓における隙間閉塞装置 |
SE8400239D0 (sv) * | 1984-01-19 | 1984-01-19 | Pharmacia Ab | Nya arylettiksyraderivat |
US4683242A (en) * | 1985-10-28 | 1987-07-28 | A. H. Robins Company, Incorporated | Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters |
US4782089A (en) * | 1986-08-26 | 1988-11-01 | A. H. Robins Company, Incorporated | 2-amino-3-aroyl-gamma-oxobenzenebutanoic acids and esters |
US4880788A (en) * | 1987-10-30 | 1989-11-14 | Baylor College Of Medicine | Method for preventing and treating thrombosis |
CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
US5179119A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof |
AU659106B2 (en) * | 1990-11-06 | 1995-05-11 | Fgn, Inc. | Method for treating colonic polyps by the use of esters and amides of substituted phenyl and pyridyl amino carboxylates |
US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
CA2288125A1 (en) * | 1997-04-28 | 1998-11-05 | Medical Information Services, Inc. | Process for producing ketoprofen and 5-benzoyl-3-methyl-2-indolinone |
AR030345A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
AR030346A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes neurodegenerativos de la retina y cabeza de nervio optico |
JP2004529110A (ja) * | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | 脈管損傷活性を有するインドール誘導体 |
US6646003B2 (en) | 2001-04-02 | 2003-11-11 | Alcon, Inc. | Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac |
US6692772B2 (en) * | 2001-07-18 | 2004-02-17 | Cedars-Sinai Medical Center | Prevention of in-stent thrombosis and complications after arterial angioplasty with stent placement using magnesium |
JP2005525408A (ja) * | 2002-05-03 | 2005-08-25 | アルコン,インコーポレイテッド | アンフェナクまたはネパフェナクを用いる血管内皮増殖因子媒介性血管障害の処置方法 |
JP4500261B2 (ja) | 2003-01-21 | 2010-07-14 | 千寿製薬株式会社 | 2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性液剤 |
US20030187072A1 (en) * | 2003-02-14 | 2003-10-02 | Kapin Michael A. | Method of treating angiogenesis-related disorders |
TWI358290B (en) * | 2004-12-02 | 2012-02-21 | Alcon Inc | Topical nepafenac formulations |
AR056968A1 (es) * | 2005-04-11 | 2007-11-07 | Xenon Pharmaceuticals Inc | Compuestos espiro-oxindol y composiciones farmacéuticas |
AR053710A1 (es) * | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
TW200812575A (en) * | 2006-04-28 | 2008-03-16 | Alcon Inc | Formulations containing amide derivatives of carboxylic acid NSAIDs for topical administration to the eye |
CA2666136A1 (en) * | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents |
WO2008046083A2 (en) * | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Use of oxindole compounds as therapeutic agents |
CA2666143A1 (en) * | 2006-10-12 | 2008-04-17 | Xenon Pharmaceuticals Inc. | Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
TW200833695A (en) * | 2006-10-12 | 2008-08-16 | Xenon Pharmaceuticals Inc | Use of spiro-oxindole compounds as therapeutic agents |
US20090105245A1 (en) * | 2006-12-21 | 2009-04-23 | Bingaman David P | Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor |
US20080153819A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
US20080153818A1 (en) * | 2006-12-21 | 2008-06-26 | Bingaman David P | Methods for preventing inflammation during surgery |
US20090076150A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched bromfenac |
BRPI0908502A2 (pt) * | 2008-02-21 | 2017-05-23 | Ista Pharmaceuticals | aines oftálmicos como adjuvantes |
CA2741024A1 (en) * | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
CN103664973B (zh) * | 2008-10-17 | 2017-04-19 | 泽农医药公司 | 螺羟吲哚化合物及其作为治疗剂的用途 |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
WO2011047173A2 (en) * | 2009-10-14 | 2011-04-21 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions for oral administration |
NZ712378A (en) | 2009-10-14 | 2017-05-26 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
GB0919757D0 (en) * | 2009-11-12 | 2009-12-30 | Johnson Matthey Plc | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
US8299295B2 (en) | 2009-10-15 | 2012-10-30 | Johnson Matthey Public Limited Company | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
GB2484843A (en) * | 2009-10-15 | 2012-04-25 | Johnson Matthey Plc | Polymorphs of Bromfenac sodium |
SG183126A1 (en) | 2010-02-26 | 2012-09-27 | Xenon Pharmaceuticals Inc | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
EP2377850A1 (de) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1-Vanilloidrezeptorantagonisten mit einem bizyklischen Teil |
WO2012084857A2 (de) * | 2010-12-21 | 2012-06-28 | Bayer Cropscience Ag | Verfahren zur herstellung von 2-(triazinylcarbonyl)sulfonaniliden |
AU2013344497B2 (en) | 2012-11-19 | 2016-04-14 | Bausch & Lomb Incorporated | Aqueous liquid composition containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
CA2911983A1 (en) | 2013-06-19 | 2014-12-24 | Sentiss Research Center | Stable bromfenac solution |
WO2015087267A2 (en) | 2013-12-12 | 2015-06-18 | Sentiss Pharma Private Limited | Stable bromfenac ophthalmic solution |
CN104974057B (zh) * | 2014-04-08 | 2018-05-18 | 天津金耀集团有限公司 | 一种溴芬酸钠的制备方法和重要中间体 |
CN104151182B (zh) * | 2014-06-16 | 2016-03-30 | 广东众生药业股份有限公司 | 一种溴芬酸钠倍半水合物的制备方法 |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
CN104693019B (zh) * | 2015-02-06 | 2017-02-01 | 宁波九胜创新医药科技有限公司 | 一种2,5‑二溴苯乙酸的制备方法 |
CN106278918B (zh) * | 2016-08-12 | 2018-05-11 | 合肥久诺医药科技有限公司 | 一种溴芬酸钠杂质标准品2-氨基-3-(4-溴苯甲酰基)苯甲酸的合成方法 |
CN106278917B (zh) * | 2016-08-12 | 2018-05-08 | 合肥久诺医药科技有限公司 | 一种溴芬酸钠降解杂质标准品的合成方法 |
WO2019004352A1 (ja) | 2017-06-30 | 2019-01-03 | 株式会社クラレ | 変性ポリビニルアルコール樹脂の製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1226344A (de) * | 1967-07-31 | 1971-03-24 | ||
US3899529A (en) * | 1973-02-22 | 1975-08-12 | Merck & Co Inc | Aroyl substituted naphthalene acetic acids |
SE400966B (sv) * | 1975-08-13 | 1978-04-17 | Robins Co Inc A H | Forfarande for framstellning av 2-amino-3-(eller 5-)bensoyl-fenylettiksyror |
-
1973
- 1973-05-15 SE SE7306852A patent/SE400966B/xx unknown
- 1973-05-15 CH CH690373A patent/CH577461A5/xx not_active IP Right Cessation
- 1973-05-16 BE BE131180A patent/BE799611A/xx not_active IP Right Cessation
- 1973-05-16 GB GB2337373A patent/GB1432576A/en not_active Expired
- 1973-05-16 CA CA171,494A patent/CA1012979A/en not_active Expired
- 1973-05-16 NL NLAANVRAGE7306833,A patent/NL183722C/xx not_active IP Right Cessation
- 1973-05-16 AT AT429873A patent/AT329542B/de not_active IP Right Cessation
- 1973-05-16 DE DE2324768A patent/DE2324768C2/de not_active Expired
- 1973-05-16 FR FR7317756A patent/FR2184934B1/fr not_active Expired
- 1973-05-17 JP JP48054205A patent/JPS523381B2/ja not_active Expired
-
1975
- 1975-08-13 US US05/604,371 patent/US4045576A/en not_active Expired - Lifetime
- 1975-10-24 PH PH17694A patent/PH12656A/en unknown
- 1975-11-04 MX MX755606U patent/MX4035E/es unknown
- 1975-12-09 GB GB50476/75A patent/GB1521097A/en not_active Expired
- 1975-12-22 AT AT977475A patent/AT347433B/de not_active IP Right Cessation
- 1975-12-29 BE BE163180A patent/BE837154A/xx not_active IP Right Cessation
-
1976
- 1976-03-19 CA CA248,319A patent/CA1087205A/en not_active Expired
- 1976-04-02 ES ES446625A patent/ES446625A1/es not_active Expired
- 1976-04-16 JP JP51043485A patent/JPS5223052A/ja active Granted
- 1976-08-13 DE DE2636582A patent/DE2636582C2/de not_active Expired
-
1977
- 1977-04-15 US US05/788,058 patent/US4126635A/en not_active Expired - Lifetime
-
1978
- 1978-02-17 US US05/879,025 patent/US4182774A/en not_active Expired - Lifetime
- 1978-12-20 JP JP15813078A patent/JPS55349A/ja active Pending
-
1979
- 1979-03-26 PH PH22318A patent/PH15112A/en unknown
-
1980
- 1980-08-27 AU AU61814/80A patent/AU530940B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PH12656A (en) | 1979-07-11 |
NL7306833A (de) | 1973-11-20 |
ATA429873A (de) | 1975-08-15 |
AT329542B (de) | 1976-05-10 |
FR2184934B1 (de) | 1976-11-05 |
DE2324768A1 (de) | 1973-11-29 |
JPS4941349A (de) | 1974-04-18 |
AU5584673A (en) | 1974-11-21 |
AU6181480A (en) | 1981-01-08 |
JPS55349A (en) | 1980-01-05 |
MX4035E (es) | 1981-11-18 |
ES446625A1 (es) | 1977-06-01 |
US4182774A (en) | 1980-01-08 |
PH15112A (en) | 1982-08-10 |
AU530940B2 (en) | 1983-08-04 |
AT347433B (de) | 1978-12-27 |
CA1012979A (en) | 1977-06-28 |
JPS5223052A (en) | 1977-02-21 |
DE2324768C2 (de) | 1985-08-14 |
JPS523381B2 (de) | 1977-01-27 |
SE400966B (sv) | 1978-04-17 |
CA1087205A (en) | 1980-10-07 |
US4126635A (en) | 1978-11-21 |
NL183722C (nl) | 1989-01-02 |
US4045576A (en) | 1977-08-30 |
BE837154A (fr) | 1976-04-16 |
CH577461A5 (de) | 1976-07-15 |
DE2636582A1 (de) | 1977-02-24 |
DE2636582C2 (de) | 1986-03-27 |
GB1432576A (en) | 1976-04-22 |
FR2184934A1 (de) | 1973-12-28 |
NL183722B (nl) | 1988-08-01 |
GB1521097A (en) | 1978-08-09 |
BE799611A (fr) | 1973-09-17 |
JPS5726585B2 (de) | 1982-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT347433B (de) | Verfahren zur herstellung von neuen 2-amino-3- (5- bzw. 6-)-benzoylphenylessigsaeuren, ihren alkylestern und salzen | |
ATA195476A (de) | Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen | |
ATA812076A (de) | Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saureadditionssalzen | |
ATA988374A (de) | Verfahren zur herstellung von neuen substituierten 1,3-dihydro-spiro- (isobenzofuran) und ihren salzen | |
AT350054B (de) | Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b)-isochinolin- derivaten und von deren saeureadditionssalzen | |
AT333296B (de) | Verfahren zur herstellung von neuen 7-fluor-substituierten phenthiazinen, ihren salzen und ihren piperazin-n-oxyden | |
ATA404376A (de) | Verfahren zur herstellung von neuen 4,4-diphenyl-2-hydroxybutylaminen und ihren salzen | |
ATA708375A (de) | Verfahren zur herstellung von neuen 4-oxo-4h-pyrano- (3,2-c)-chinolin-2-carbonsauren und ihren salzen | |
AT346825B (de) | Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo(2,2,2)octanen und -octenen und deren saeureadditionssalzen | |
ATA195576A (de) | Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
ATA985075A (de) | Verfahren zur herstellung von neuen polysubstituierten 10-piperazinodibenzo/b,f/tiepinderivaten und von deren salzen | |
AT348524B (de) | Verfahren zur herstellung von neuen naphthyridinderivaten und von deren saeureadditionssalzen | |
ATA194876A (de) | Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
AT352735B (de) | Verfahren zur herstellung von neuen 2,4- diamino-5-benzylpyrimidinen und deren saeure- additionssalzen | |
ATA424575A (de) | Verfahren zur herstellung von neuen aminoalkylphenoxyalkansaeuren, deren estern und salzen | |
AT330737B (de) | Verfahren zur herstellung von n-cyclohexyl-n-methyl-2-amino-3,5-dibrombenzylamin und dessen saureadditionssalzen | |
AT330146B (de) | Verfahren zur herstellung von 2-amino-3,5-dibrom -n-methyl-n- cyclohexyl-benzylamin und dessen saureadditionssalzen | |
ATA195176A (de) | Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
ATA195276A (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen | |
AT339331B (de) | Verfahren zur herstellung von neuen 1-hydroxy -2,2,2 -trichlorathan-tionophosphonsauredialkylestern | |
AT349476B (de) | Verfahren zur herstellung von neuen phenoxy- alkancarbonsaeurederivaten von 1-cinnamyl-4- diphenylmethylpiperazin | |
ATA724676A (de) | Verfahren zur herstellung von neuen, substituierten 2-alkyl-5-indanessigsauren und von deren salzen | |
ATA431876A (de) | Verfahren zur herstellung von neuen n,n-disubstituierten aminoessigsaurederivaten | |
AT342575B (de) | Verfahren zur herstellung von neuen 3,4-dichlorphenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
ATA27577A (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EIH | Change in the person of patent owner | ||
ELA | Expired due to lapse of time |